Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Raymos (Laboratorios Raymos) is a prominent Argentine pharmaceutical company that specializes in women's health, endocrinology, and reproductive medicine. The company provides a wide range of therapeutic solutions, including hormonal replacements, fertility treatments, and contraceptives, maintaining a significant market share in the Southern Cone. In 2021, Raymos was acquired by Eurofarma, a leading Brazilian multinational pharmaceutical corporation, to strengthen its regional presence and specialized portfolio. Raymos operates advanced manufacturing facilities in Buenos Aires, focusing on high-quality production standards for complex hormonal products. Its portfolio includes well-known brands such as Progendo and Divina, which are essential in the management of hormonal disorders and assisted reproduction.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Raymos.